2010 revenues grew 32.1% to RMB418.6 million (US$63.4 million) 2011 revenues expected to grow 20%...
SHENYANG, China, Feb. 19, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or ...
SHENYANG, China, Jan. 25, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or ...
SHENYANG, China, Nov. 29, 2010 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company")...
SHENYANG, China, Nov. 23, 2010 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company")...
SHENYANG, China, Nov. 19, 2010 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a...
Third quarter revenues grew 24.9% year-over-year to RMB115.6 million (US$17.3 million); First nine m...
SHENYANG, China, Oct. 18 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the C...
SHENYANG, China, Sept. 27 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "...
SHENYANG, China, Sept 14 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a ...
SHENYANG, China, Sept. 7 /PRNewswire-Asia/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a leading Chi...
SHENYANG, China, Aug. 24 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a lead...
SHENYANG, China, Aug. 18 /PRNewswire-Asia-FirstCall/ -- -- Second quarter revenues grew 29.5...
SHENYANG, China, Aug. 5 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or...
SHENYANG, China, June 28 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio"...
Net revenues grew 40.5% year-on-year to RMB96.4 million (US$14.1 million) Net income grew...
SHENYANG, China, May 11 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Compan...
SHENYANG, China, March 10 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnolog...
Company exceeds guidance with 2009 revenue of RMB316.9 million (US$46.4 million) Full-year 2009...
SHENYANG, China, Feb. 12 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology...